Branch Retinal Artery Occlusion: Causes, Treatment, and Outcomes
Understanding Branch Retinal Artery Occlusion
Branch retinal artery occlusion, or BRAO, is a blockage in one of the smaller arteries that deliver blood to the retina, the light-sensitive tissue lining the back of the eye. The condition is more than just an eye problem. It is closely linked to cardiovascular disease and requires attention beyond a routine eye exam.
The retinal arteries divide into progressively smaller branches as they spread across the retinal surface, each branch supplying a specific zone of retinal tissue. When one of these branches becomes blocked, the section of retina it supplies loses blood flow and becomes ischemic, meaning it is deprived of oxygen. This creates a wedge-shaped area of retinal swelling and whitening that shows up clearly on examination and corresponds to a region of missing or darkened vision for the patient. The temporal, or outer-facing, retinal vessels are involved in the large majority of cases.
The most common cause of BRAO is an embolus, a small particle that breaks free from somewhere else in the circulatory system and travels through the bloodstream until it lodges in a retinal artery. Emboli are actually visible during a dilated eye exam in a large portion of BRAO cases. The three most common types are cholesterol emboli, sometimes called Hollenhorst plaques, which break off from fatty deposits in the carotid arteries in the neck; platelet-fibrin emboli from blood clots; and calcific emboli from hardened heart valves. Less common causes include inflammation of the blood vessels (vasculitis), arterial spasm (vasospasm), and blood-clotting disorders known as hypercoagulable states.
Many vascular specialists consider BRAO a stroke equivalent. The same embolic sources that block a retinal artery can also send particles to the arteries supplying the brain, which can cause a stroke or a transient ischemic attack (TIA), sometimes called a mini-stroke. Research has found that a meaningful percentage of patients diagnosed with retinal artery occlusion have already experienced or go on to experience ischemic cerebrovascular disease. This is why a thorough cardiovascular evaluation is considered an essential and urgent part of care after a BRAO diagnosis.
Who Is at Risk for BRAO?
BRAO shares the same risk factor profile as atherosclerotic cardiovascular disease, meaning the conditions that affect the heart and major blood vessels also raise the risk for this retinal event. Knowing these risk factors helps both patients and providers take preventive steps.
BRAO most commonly affects adults over the age of 60, and it occurs slightly more often in men than in women. However, BRAO can also affect younger patients, particularly those with structural heart conditions that produce emboli, inherited clotting disorders, or inflammatory vascular disease. Age alone does not determine risk, and younger patients with unexplained BRAO often require a broader workup to identify the underlying cause.
The risk factors most strongly associated with BRAO include high blood pressure (hypertension), which is the most common systemic condition found in BRAO patients, along with diabetes, elevated cholesterol (hyperlipidemia), and smoking. Additional risk factors include narrowing of the carotid arteries (carotid stenosis), an irregular heart rhythm called atrial fibrillation, and disease of the heart valves. A personal history of prior stroke or TIA also raises the risk. Patients who have already been diagnosed with cardiovascular disease should be aware that BRAO can be a direct manifestation of that underlying condition.
Symptoms and Warning Signs
BRAO produces a distinct pattern of visual symptoms that differ from other eye emergencies. Recognizing these symptoms early and responding quickly can make an important difference in how the condition is managed.
BRAO presents with sudden, painless loss of a portion of the visual field in one eye. Patients often describe noticing a shadow, a blank spot, or a darkened area in part of their vision that appeared without any warning or discomfort. The area of vision loss corresponds to the zone of retina supplied by the blocked artery. Depending on which branch is affected, the vision loss may affect the upper or lower half of the field, a wedge-shaped sector, or the central area of vision if the artery supplying the macula (the central region of the retina) is involved.
Some patients with BRAO report one or more prior episodes where part of their vision went temporarily dark and then returned to normal. This temporary dimming is called amaurosis fugax, and it represents an embolus that briefly blocked the artery before breaking apart or passing through. These transient episodes are a serious warning sign that should not be ignored, even when vision returns completely. They may indicate that a more sustained occlusion, or a cerebrovascular event, is on the way. Urgent evaluation after any episode of transient visual loss can allow intervention before a more significant event occurs.
During a dilated eye exam after BRAO, the retina in the affected zone appears pale, swollen, and whitened compared to the surrounding healthy tissue, forming a distinct wedge-shaped area. An embolus may be visible as a small, bright deposit lodged at an artery branch point. The artery supplying the affected area may appear narrowed or appear to have reduced blood flow. Over time, the retinal whitening fades as swelling resolves, but the visual field defect may remain even after the eye looks more normal on examination.
Diagnosis and Evaluation
Diagnosing BRAO involves a combination of clinical examination, advanced retinal imaging, and cardiovascular testing. Because of the systemic implications, the evaluation goes well beyond the eye itself.
BRAO is primarily a clinical diagnosis, meaning a retina specialist can usually identify it during the initial dilated fundus examination based on the characteristic findings in the retina. Automated visual field testing is used to document the exact extent of the vision loss and to create a baseline for tracking any recovery over time.
Optical coherence tomography (OCT) is an imaging tool that captures detailed cross-sectional images of the retinal layers. After BRAO, OCT shows thickening and increased brightness of the inner retinal layers in the affected area, consistent with ischemic swelling. Fluorescein angiography, a study that uses a dye injected into the arm to illuminate the retinal blood vessels, can show delayed or absent filling in the affected artery and its territory. These imaging studies help confirm the diagnosis and distinguish BRAO from other conditions that can cause similar visual field loss.
A comprehensive cardiovascular evaluation is recommended for all patients diagnosed with BRAO, and the urgency of this evaluation is real given the association with stroke risk. This typically includes duplex ultrasound of the carotid arteries to check for narrowing or plaques, an echocardiogram (ultrasound of the heart) to look for structural sources of emboli, an electrocardiogram (ECG) to screen for atrial fibrillation, and blood tests to evaluate blood sugar, cholesterol, and inflammatory markers. Coordination with a primary care physician, cardiologist, or neurologist is often part of this process.
For patients who are younger or who do not have the typical cardiovascular risk factors, a more expanded evaluation may be needed. This can include testing for inherited blood-clotting disorders, autoimmune conditions, and inflammatory diseases affecting the blood vessels (vasculitis). Identifying less common causes of BRAO is important because they may require specific treatments that differ from standard cardiovascular risk management.
Treatment and Management
Treatment for BRAO focuses on two priorities: addressing what is happening in the eye and reducing the systemic risk that led to the occlusion. Both are essential parts of a complete management plan.
There is currently no treatment that has been proven to definitively restore blood flow once a branch retinal artery becomes blocked. Ocular massage may be attempted in the very early stages in an effort to dislodge the embolus and allow it to move to a smaller, less critical vessel, but the evidence supporting this approach is limited. Because many BRAO cases show some degree of spontaneous improvement as the embolus naturally fragments or collateral blood flow develops, careful observation and close monitoring is a common management strategy while cardiovascular evaluation proceeds in parallel.
Managing the underlying vascular disease is the most critical step in long-term BRAO care. This typically involves controlling blood pressure through medication and lifestyle changes, managing diabetes and cholesterol, stopping smoking, and starting antiplatelet therapy (such as aspirin) when your physician determines it is appropriate. Patients found to have significant carotid artery narrowing may be candidates for a surgical or minimally invasive procedure to open the artery. Patients with atrial fibrillation or other cardiac sources of emboli may require anticoagulation (blood-thinning) medication. These decisions are made by your vascular or primary care team based on your individual evaluation results.
In a small number of cases, BRAO can lead to the growth of abnormal new blood vessels on the retina, a process called neovascularization, if significant areas of retinal ischemia remain over time. If neovascularization is detected, laser photocoagulation may be applied to the affected retinal tissue to reduce the risk of bleeding into the vitreous (the gel inside the eye). Most patients with BRAO do not develop this complication, but periodic retinal monitoring is important so that it can be identified and addressed promptly if it does occur.
What to Expect After BRAO
Recovery after BRAO varies from person to person, and understanding what is realistic helps patients stay engaged with both their eye care and their overall health management.
Many patients with BRAO experience some improvement in their visual field over time as retinal swelling resolves and collateral blood supply develops. Central visual acuity (the sharpness of central vision) is often preserved or recovers to a functional level, particularly when the macular blood supply was not fully disrupted. However, a residual area of visual field loss may remain, especially when the initial occlusion affected a larger area of retina or the blockage persisted for a longer period. The extent of recovery depends on the size of the involved area, how long the artery was blocked, and the individual's capacity for collateral circulation.
BRAO is a signal from your body that something needs attention in your vascular system beyond your eyes. Adhering to prescribed cardiovascular medications, maintaining blood pressure and blood sugar targets, and attending follow-up appointments with your primary care physician or cardiologist are all critical for reducing the risk of a future stroke or heart event. Patients should also learn the warning signs of stroke, including sudden weakness or numbness, difficulty speaking, or sudden severe headache, and seek emergency care immediately if those symptoms occur.
After the initial event, ongoing monitoring by both a retina specialist and a primary care or cardiovascular provider is important. Eye follow-up checks for complications such as neovascularization and tracks any changes in the visual field. Systemic follow-up ensures that risk factors are being adequately controlled. The other eye should also be monitored over time, as the underlying vascular disease that caused BRAO can potentially affect both eyes.
When to Seek Urgent Care
Some symptoms related to BRAO require immediate attention. Acting quickly can influence both the eye exam findings and the opportunity to prevent a more serious vascular event.
Any sudden, painless loss of a section of your vision in one eye should be evaluated the same day. Even if central vision appears intact and you feel no discomfort, partial visual field loss is an urgent finding. The systemic implications of BRAO, particularly the stroke risk, mean that waiting is not a safe option. A same-day evaluation allows for prompt diagnosis, retinal imaging, and referral for cardiovascular testing when needed.
If part of your vision goes dark or blurry and then returns to normal, do not assume everything is fine simply because the symptom resolved. Transient episodes of visual loss can precede a more sustained retinal artery occlusion or a cerebrovascular event. Prompt evaluation after even a brief episode of visual disturbance can identify an embolic source and allow your care team to intervene before something more serious occurs.
Frequently Asked Questions
Below are answers to questions our patients commonly ask about BRAO, beyond what is covered in detail above.
No, they are related but distinct conditions. A central retinal artery occlusion (CRAO) affects the main trunk of the retinal artery and typically causes much more severe and widespread vision loss in the affected eye, often including nearly complete loss of central vision. BRAO involves only one of the smaller branches, so the vision loss is usually limited to a sector of the visual field while central vision may be spared. Both conditions are vascular emergencies requiring urgent evaluation, but BRAO generally carries a better visual prognosis than CRAO.
Yes, recurrence is possible, particularly if the underlying vascular risk factors are not adequately managed. The same embolic sources that caused the first event can produce additional emboli over time. This is one of the central reasons why managing blood pressure, cholesterol, heart rhythm, and other cardiovascular factors is so important after a BRAO diagnosis. Your retina specialist and primary care provider will work together to reduce that ongoing risk as much as possible.
Sudden visual field loss should be evaluated urgently, and the most appropriate first step depends on your symptoms and how quickly you can reach a specialist. If you also have symptoms that could indicate a stroke, such as weakness, numbness, confusion, or speech difficulty, call emergency services immediately. For isolated visual field loss without other neurological symptoms, contacting a retina specialist the same day is the right approach. Your provider can advise on whether same-day imaging or emergency referral is needed based on your specific situation.
Visual improvement does not necessarily mean the underlying problem has been resolved. Even when visual symptoms partially recover, the embolic source that caused the BRAO is often still present and continues to pose a risk for future events. Cardiovascular evaluation and risk factor management remain just as important whether or not the vision has improved. Follow-up retinal exams are also needed to monitor for delayed complications, even when early recovery appears encouraging.
There is no single medication that prevents BRAO in all patients, but managing the conditions that contribute to embolus formation, such as high blood pressure, atrial fibrillation, and elevated cholesterol, significantly reduces risk. Antiplatelet agents and anticoagulants may be prescribed for patients whose evaluation identifies a specific indication, but these decisions are individualized based on the cardiovascular workup findings. Lifestyle factors, including not smoking and maintaining a healthy diet, also play an important supporting role.
Care for BRAO at Rhode Island Eye Institute
If you or a family member experiences sudden visual field loss or any transient visual symptoms, our team is here to help. At Rhode Island Eye Institute, our retina specialists Dr. Gaurav Gupta and Dr. Pranjal Thakuria bring focused subspecialty expertise to the diagnosis and management of retinal vascular conditions, including BRAO, and work closely with your broader medical team to address both the visual and systemic aspects of your care. With multiple convenient locations and a team of fellowship-trained specialists committed to your long-term vision health, we are ready to provide the thorough, expert evaluation your situation deserves.